Influence of early postnatal nutritional management on oxidative stress and antioxidant defence in extreme prematurity

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 2, 2006, Pages 153-163

  Yeung, Melinda Y ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Antioxidant defence; Extreme prematurity; Lipid peroxidation; Neurodevelopment; Parenteral nutrition

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; INTRALIPID; LIPOSYN; MULTIVITAMIN; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN;

ANTIOXIDANT ACTIVITY; BRAIN DEVELOPMENT; CELL FUNCTION; GESTATIONAL AGE; HUMAN; HYPEROXIA; HYPOXIA; LIPID PEROXIDATION; NEWBORN INTENSIVE CARE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARENTERAL NUTRITION; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW;

AGE FACTORS; ANTIOXIDANTS; BRAIN; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE, NEONATAL; LIPID PEROXIDATION; OXIDATIVE STRESS; PARENTERAL NUTRITION;

EID: 31944432244     PISSN: 08035253     EISSN: 15023869     Source Type: Journal    
DOI: 10.1080/08035250500301133     Document Type: Review

References (85)

1. Saugstad OD. Oxygen radical disease in neonatology. Semin Neonatol 1998;3:229-38.
2. O'Donovan DJ, Fernandes CJ. Free radicals and diseases in premature infants. Antioxid Redox Signal 2004;6:169-76.
3. Gitto E, Reiter RJ, Karbownik M, Tan D-X, Gitto P, Barberi S, et al. Causes of oxidative stress in the pre- and perinatal period. Biol Neonate 2002;81:146-57.
4. Mylonas C, Kouretas D. Lipid peroxidation and tissue damage. In Vivo 1999;13:295-309.
5. Baud O, Haynes RF, Wang H, Folkerth RD, Li J, Volpe JJ, et al. Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. Eur J Neurosci 2004;20:29-40.
6. Buonocore G, Perrone S, Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 2001;79:180-6.
7. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998;18:6241-53.
8. Taglialatela G, Perez-Polo JR, Rassin DK. Induction of apoptosis in the CNS during development by the combination of hyperoxia and inhibition of glutathione synthesis. Free Radic Biol Med 1998;25:936-42.
9. Sapolsky RM, Meaney MJ. Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res Rev 1986;396:64-76.
10. Halliwell B. The antioxidant paradox. Lancet 2000;355:1179-80.
11. Fentone JC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982;107:397-418.
12. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991;161:488-503.
13. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatr Suppl 1994;395:49-57.
14. Bowry VW, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant. Biochem J 1992;288:341-4.
15. Bowry VW, Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993;115:6029-40.
16. Ingold KU, Bowry VW, Stocker R, Walling C. Autooxidation of lipids and antioxidation by α-tocopherol and ubiquinol in homogenous solution and in aqueous dispersions of lipids. The unrecognized consequences of lipid particle size as exemplified by the oxidation of human low-density lipoprotein. Proc Natl Acad Sci USA 1993;90:45-9.
17. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 1991;88:1646-50.
18. Neužil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994;269:16712-9.
19. Njålsson R, Norgren S. Physiological and pathological aspects of GSH metabolism. Acta Paediatr 2005;94:132-7.
20. Levonen AL, Lapatto R, Saksela M, Raivio KO. Expression of (gamma)-glutamylcysteine synthetase during development. Pediatr Res 2000;47:266-70.
21. Constantinescu A, Han D, Packer L. Vitamin E recycling in human erythrocyte membranes. J Biol Chem 1993;268:10906-13.
22. Freisleben H-J, Packer L. Free-radical scavenging activities, interactions and recycling of antioxidants. Biochem Soc Trans 1993;21:325-30.
23. Xu DP, Washburn MP, Sun GP, Wells WW. Purification and characterization of a glutathione dependent dehydroascorbate reductase from human erythrocytes. Biochem Biophys Res Commun 1996;221:117-21.
24. May JM, Qu Z-C, Whitesell RR, Cobb CE. Ascorbate recycling in human erythrocytes: Role of GSH in reducing dehydroascorbate. Free Rad Biol Med 1996;20:543-51.
25. DeLeve LD, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 1991;52:287-305.
26. Lavoie JC, Chessex P. Gender and maturation affect glutathione status in human neonatal tissues. Free Radical Biol Med 1997;23:648-57.
27. Meister A, Anderson ME, Hwang O. Intracellular cysteine and glutathione delivery systems. J Am Coll Nutr 1986;5:137-51.
28. Beutler E. Nutritional and metabolic aspect of glutathione. Annu Rev Nutr 1989;9:287-302.
29. Kang YJ, Feng Y, Hatcher EL. Glutathione stimulates A549 cell proliferation in glutamine-deficient culture: The effect of glutamate supplementation. J Cell Physiol 1994;161:589-96.
30. Orten JM, Neuhaus OW. Metabolism of amino acids. In: Orten JM, Neuhaus OW, editors. Human biochemistry. Saint Louis: The C. V. Mosby Company; 1982. p. 342.
31. Devlin Thomas M. Amino acid metabolism II: Metabolism of the individual amino acids. In: Devlin Thomas M, editor. Textbook of biochemistry with clinical correlations. New York: Wiley-Liss, Inc.; 1993. p. 524.
32. Deneke SM, Fanburg BL. Regulation of cellular glutathione. Am J Physiol 1989;257:L163-73.
33. Meister A, Griffith OW, Novogrodsky A, Tate SS. New aspects of glutathione metabolism and translocation in mammals. Ciba Foundation Symposium 1979;72:135-61.
34. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol Ther 1991;51:155-94.
35. Chow CK. Vitamin E and oxidative stress. Free Radical Biol Med 1991;11:215-32.
36. Moran JR, Greene HL. Vitamin requirements. In: Polin RA, Fox WW, editors. Fetal and neonatal physiology. Philadelphia: Saunders; 1992. p. 248-57.
37. 6, niacin, biotin and pantothenic acid. In: Tsang RC, Nichols BL, editors. Nutrition during infancy. Philadelphia: Hanley & Belfus; 1988. p. 236-52.
38. Adlard BPF, De Souza SW, Moon S. Ascorbic acid in the fetal human brain. Arch Dis Child 1974;49:278-82.
39. Lindeman JHN, Van Zoeren-Grobben D, Schrijver J, Speek AJ, Poorthuis JHM, Berger HM. The total free radical trapping ability of cord blood plasma in preterm and term babies. Pediatr Res 1989;26:20-4.
40. Berger TM, Rifai M, Avery ME, Frei B. Vitamin C in premature and full term human neonates. Redox Rep 1996;2:257-62.
41. Bohles H. Antioxidative vitamins in prematurely and maturely born infants. Int J Vitam Nutr Res 1997;67:321-8.
42. Vina J, Vento M, Garcia-Sala F, Puertes IR, Gasco E, Sastre J, et al. L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am J Clin Nutr 1995;61:1067-9.
43. Kondo M, Itoh S, Isobe K, Dondo M, Kunikata T, Imai T, et al. Chemiluminescence because of the production of reactive oxygen species in the lungs of newborn piglets during resuscitation periods after asphyxiation load. Pediatr Res 2000;47:524-7.
44. Freeman BA, Topolsky MK, Crapo JD. Hyperoxia increases oxygen radical production in rat lung homogenates. Arch Biochem Biophys 1982;216:477-84.
45. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989;140:531-54.
46. Smith CV, Hansen TN, Martin NE, McMicken HW, Elliott SJ. Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr Res 1993;34:360-5.
47. Jain A, Mehta T, Auld PA, Rodrigues J, Ward RF, Schwartz MK, et al. Glutathione metabolism in newborns: evidence for glutathione deficiency in plasma, bronchoalveolar lavage fluid, and lymphocytes in prematures. Pediatr Pulmonol 1995;20:160-6.
48. Grigg J, Barger A, Silverman M. Bronchoalveolar lavage fluid glutathione in intubated premature infants. Arch Dis Child 1993;69:45-51.
49. Picone TA, Daniels TA, Ponto KH. Cord blood tryptophan concentrations and total cysteine concentrations. JPEN 1989;13:106-7.
50. Lavoie JC, Chessex P. Development of glutathione synthesis and gamma-glutamyltranspeptidase activities in tissues from new infants. Free Radic Biol Med 1998;24:994-1001.
51. Lavoie JC, Rouleau T, Truttmann AC, Chessex P. Postnatal gender-dependent maturation of cellular cysteine uptake. Free Radic Res 2002;36:811-7.
52. White CW, Stabler SP, Allen RH, Moreland S, Rosenberg AA. Plasma cysteine concentrations in infants with respiratory distress. J Pediatr 1994;125:769-77.
53. Nemeth I, Boda D. Blood glutathione redox ratio as a parameter of oxidative stress in premature infants with IRDS. Free Radic Biol Med 1994;16:347-53.
54. Taniguchi M, Hiramaya K, Yamaguchi N, Tateishi N, Suzuki M. In: Dolphin D, Poulson R, Avramovic O, editors. Gutathione: chemical, biochemical and medical aspects, part B. Wiley: New York; 1989. p. 645-727.
55. Amores-Sanchez MI, Medina MA. Glutamine, as a precursor of glutathione, and oxidative stress. Mol Genet Metab 1999;67:100-5.
56. Klimberg VS, McClellan JL. Glutamine, cancer, and its therapy. Am J Surg 1996;172:418-24.
57. Scott PH, Berger HM, Kenward C, Scott P, Wharton BA. Effect of gestational age and intrauterine nutrition on the plasma transferrin and iron in the newborn. Arch Dis Child 1975;80:796-8.
58. Moison RMW, Palinckx JJS, Roest M, Houdkamp E, Berger HM. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993;341:79-82.
59. Berger HM. Extracellular defense against oxidative stress in the newborn. Semin Neonatol 1998;3:183-90.
60. Horwitt MK, Harvey CC, Dahm Jr CC, Seary MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann NY Acad Sci 1972;203:223-6.
61. Haga P, Ek J, Kran S. Plasma tocopherol levels and vitamin E/ beta-lipoprotein relationships during pregnancy and in cord blood. Am J Clin Nutr 1982;36:1200-4.
62. Wu SC, Chou YH. Measurement of serum vitamin E isomers in fullterm and preterm infants. Chang Gung Med J 2001;24:793-8.
63. Traber MG, Kayden HJ. Vitamine E is delivered to cells via the high affinity receptor for low-density lipoprotein. Am J Clin Nutr 1984;40:747-51.
64. McMurchie EJ, Darrie MM, Beilin LJ, Croft KD, Vandongen R, Armstrong BK. Dietary induced changes in fatty acid composition of human cheek phospholipids: correlation with changes in the dietary polyunsaturated/saturated fat ratio. Am J Clin Nutr 1984;39:975-80.
65. Teupser D, Thiery J, Seidel D. Alpha-tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis 1999;144:109-15.
66. Brion LP, Bell EF, Raghuveer TS. Vetamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev (computer file); 2003.3:CD003665.
67. Rehman A, Collis CS, Yang M, Kelly M, Diplock AT, Halliwell B, et al. The effects of iron and vitamin C co-supplementation oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 1998;246:293-8.
68. Beatty ER, England TG, Geissler CA, Aruoma OI, Halliwell B. Effects of antioxidant vitamin supplementation on markers of DNA damage and plasma antioxidant. Proc Nutr Sco 1999;58:44 (abstract).
69. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998;392:559.
70. Ahola T, Lapatto R, Raivo KO, Selander B, Stigson L, Jonsson B, et al. N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: A randomized controlled trial. J Pediatr 2003;143:713-9.
71. Ahola T, Fellman V, Kjellmer I, Raivio KO, Lapatto R. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia. Pediatr Res 2004;56:88-93.
72. Lavoie JC, Chessex P. Peroxides infused at concentrations found in pediatric regimens of parenteral nutrition interfere with a key antioxidant. Pediatr Res (Abstr) 1997;41:235A.
73. Lavoie JC, Bélanger S, Spalinger M, Chessex P. Admixture of a multivitamin preparation to parenteral nutrition: The major contributor to in vitro generation of peroxides. Pediatrics 1997;99:E6.
74. Laborie S, Lavoie JC, Chessex P. Paradoxical role of ascorbic acid and riboflavin in solutions of TPN: Implication in photoinduced peroxide generation. Pediatr Res 1998;43:601-6.
75. Laborie S, Lavoie JC, Pineault M, Chessex P. Protecting solutions of parenteral nutrition from peroxidation. JPEN 1999;23:104-8.
76. Neužil J, Darlow BA, Inder TE, Sluis KB, Winterbourn CC, Stocker R. Oxidation of parenteral lipid emulsion by ambient and phototherapy lights: Potential toxicity of routine parenteral feeding. J Pediatr 1995;126:785-90.
77. Silvers KM, Sluis KB, Darlow BA, McGill F, Stocker R, Winterbourn CC. Limiting light-induced lipid peroxidation and vitamin loss in infants' parenteral nutrition by adding multivitamin preparations to Intralipid. Acta Paediatr 2001;90:242-9.
78. Kim H, Kirschenbaum LJ, Rosenthal I, Riesz P. Photosensitized formation of ascorbate radicals by riboflavin: an ESR study. Photochem Photobiol 1993;55:777-84.
79. Berghaus TM, Demmelmair H, Koletzko B. Fatty acid composition of lipid classes in maternal and cord plasma at birth. Eur J Pediatr 1998;157:763-8.
80. Wiedemann M, Kontush A, Finckh B, Hellwege H-H, Kohlschütter A. Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable fatty acids. Pediatr Res 2003;53:843-9.
81. Göbel Y, Koletzko B, Böhles H-J, Engelsberger I, Forget D, Brun AL, et al. Parenteral fat emulsions based on olive and soybean oils: A randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr 2003;37:161-7.
82. Koletzko B, Edenhofer S, Lipowsky G, Reinhardt D. Effects of a low birthweight infant formula containing docoxahexaenoic and arachidonic acids at human milk levels. J Pediatr Gastroenterol 1995;21:200-8.
83. 13C-labeled linoleic acid in newborn infants during the first week of life. Pediatr Res 1999;45:669-73.
84. Chan S, McCowen KC, Bistrian B. Medium-chain triglyceride and n-3 polyunsaturated fatty acid-containing emulsions in intravenous nutrition. Curr Opin Clin Nutr Metab Care 1998;1:163-9.
85. Koch T, Heller AR. Effects of intravenous fish oil on pulmonary integrity and function. Clin Nutr 2002;21 Suppl 2:41-5.